Skip to main content

Dr. Charles Burger, MD

Pulmonology (Pulmonary Disease Physician)

  • Medicare participating

At a glance

Years since graduation
41
In the NPI registry since
2005
Medicare patients seen, 2024
114

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 1985Medical school: Wake Forest University School of Medicine
  • 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Pulmonary Disease Physician primary
    FL license ME57557

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Pulmonology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
114
Services billed
158
Patients’ average age
70
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 30-39 minutes9985
Established patient office or other outpatient visit, 40-54 minutes7563
Test to examine how well the lungs exchange gases7171
Test to determine lung volumes using sensors6767
Test to measure expiratory airflow and volume5551
Test to measure expiratory airflow and volume changes before and after medication administration4242
New patient office or other outpatient visit, 60-74 minutes4040
New patient office or other outpatient visit, 45-59 minutes3535
Test for exercise-induced heart and lung stress3329
Test for exercise-induced lung stress2625

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Most prescribed drugs, Medicare Part D 2024
DrugPrescriptions
Ambrisentan201
Opsumit (macitentan)190
Sildenafil Citrate
Other prescribers in Jacksonville, FL
160
Tadalafil126
Adempas (riociguat)125
Spironolactone
Other prescribers in Jacksonville, FL
73
Furosemide
Other prescribers in Jacksonville, FL
73
Uptravi (selexipag)43
Prednisone
Other prescribers in Jacksonville, FL
30
Bumetanide
Other prescribers in Jacksonville, FL
28

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 7 companies reported 39 payments worth $23,922 in total to this clinician.

By type
Consulting Fee$20,310
Travel and Lodging$1,818
Food and Beverage$1,794

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Nov 24, 2025Merck Sharp & Dohme LLC
Nov 24, 2025
Consulting Fee$10,240
Jun 22, 2025Insmed, Inc.
Jun 22, 2025
Consulting Fee$5,030
Dec 10, 2025Merck Sharp & Dohme LLC
Dec 10, 2025
Consulting Fee$3,840
Jun 16, 2025Actelion Pharmaceuticals US, Inc.
Jun 16, 2025
Consulting Fee
OPSUMIT · Cardiology
$1,000
Nov 13, 2025Merck Sharp & Dohme LLC
Nov 13, 2025
Travel and Lodging
WINREVAIR · CARDIOVASCULAR · travel to Plano, TX · in-kind
$387
Dec 3, 2025Merck Sharp & Dohme LLC
Dec 3, 2025
Travel and Lodging
WINREVAIR · CARDIOVASCULAR · travel to Boston, MA · in-kind
$282
Nov 13, 2025Merck Sharp & Dohme LLC
Nov 13, 2025
Travel and Lodging
WINREVAIR · CARDIOVASCULAR · travel to Plano, TX · in-kind
$256
Nov 14, 2025Merck Sharp & Dohme LLC
Nov 14, 2025
Travel and Lodging
WINREVAIR · CARDIOVASCULAR · travel to Plano, TX · in-kind
$256
Nov 13, 2025Merck Sharp & Dohme LLC
Nov 13, 2025
Travel and Lodging
WINREVAIR · CARDIOVASCULAR · travel to Plano, TX · in-kind
$221
Sep 30, 2025Bayer HealthCare Pharmaceuticals Inc.
Sep 30, 2025
Consulting Fee
Adempas · Cardio-pulmonary
$200
All 13 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Dec 10, 2025Merck Sharp & Dohme LLC
Dec 10, 2025
Consulting Fee$3,840
Dec 10, 2025Merck Sharp & Dohme LLC
Dec 10, 2025
Travel and Lodging
travel to Boston, MA
$150
Dec 3, 2025Merck Sharp & Dohme LLC
Dec 3, 2025
Travel and Lodging
WINREVAIR · CARDIOVASCULAR · travel to Boston, MA · in-kind
$282
Nov 24, 2025Merck Sharp & Dohme LLC
Nov 24, 2025
Consulting Fee$10,240
Nov 24, 2025Merck Sharp & Dohme LLC
Nov 24, 2025
Travel and Lodging
travel to Dallas, TX
$150
Nov 14, 2025Merck Sharp & Dohme LLC
Nov 14, 2025
Travel and Lodging
WINREVAIR · CARDIOVASCULAR · travel to Plano, TX · in-kind
$256
Nov 13, 2025Merck Sharp & Dohme LLC
Nov 13, 2025
Travel and Lodging
WINREVAIR · CARDIOVASCULAR · travel to Plano, TX · in-kind
$387
Nov 13, 2025Merck Sharp & Dohme LLC
Nov 13, 2025
Travel and Lodging
WINREVAIR · CARDIOVASCULAR · travel to Plano, TX · in-kind
$256
Nov 13, 2025Merck Sharp & Dohme LLC
Nov 13, 2025
Travel and Lodging
WINREVAIR · CARDIOVASCULAR · travel to Plano, TX · in-kind
$221
Nov 13, 2025Merck Sharp & Dohme LLC
Nov 13, 2025
Travel and Lodging
WINREVAIR · CARDIOVASCULAR · travel to Plano, TX · in-kind
$116
Sep 30, 2025Bayer HealthCare Pharmaceuticals Inc.
Sep 30, 2025
Consulting Fee
Adempas · Cardio-pulmonary
$200
Jun 22, 2025Insmed, Inc.
Jun 22, 2025
Consulting Fee$5,030
Jun 16, 2025Actelion Pharmaceuticals US, Inc.
Jun 16, 2025
Consulting Fee
OPSUMIT · Cardiology
$1,000

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Florida →

Industry-funded research

Named as a principal investigator on 6 industry-funded studies in 2025, from 2 companies. The companies reported $808,730 in research payments for these studies, mostly to the institutions running them.

  • A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sotatercept When Added to Maximum Tolerated Background Therapy in Participants With Pulmonary Arterial Hypertension PAH World Health Organizati…
    Merck Sharp & Dohme LLC
  • A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Sotatercept versus Placebo for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension Cpc-PH due to Hea…
    Merck Sharp & Dohme LLC
  • A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
    United Therapeutics Corporation · Completed · NCT03626688
  • An Open-Label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Background Pulmonary Arterial Hypertension PAH Therapy for the Treatment of PAH
    Merck Sharp & Dohme LLC
  • An Open-label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Background Pulmonary Arterial Hypertension PAH Therapy for the Treatment of PAH MK-7962-038
    Merck Sharp & Dohme LLC
  • A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
    United Therapeutics Corporation · Enrolling by invitation · NCT03683186

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Pulmonology clinicians in Jacksonville

Sources

NPI registry (CMS NPPES, November 2026; record last updated August 31, 2020), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1790772671. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.